Abstract
Background: There is an urgent need to better understand the mechanisms underlying acute and long-term neurological symptoms after COVID-19. Neuropathological studies can contribute to a better understanding of some of these mechanisms. Methods: We conducted a detailed postmortem neuropathological analysis of 32 patients who died due to COVID-19 during 2020 and 2021 in Austria. Results: All cases showed diffuse white matter damage with a diffuse microglial activation of a variable severity, including one case of hemorrhagic leukoencephalopathy. Some cases revealed mild inflammatory changes, including olfactory neuritis (25%), nodular brainstem encephalitis (31%), and cranial nerve neuritis (6%), which were similar to those observed in non-COVID-19 severely ill patients. One previously immunosuppressed patient developed acute herpes simplex encephalitis. Acute vascular pathologies (acute infarcts 22%, vascular thrombosis 12%, diffuse hypoxic–ischemic brain damage 40%) and pre-existing small vessel diseases (34%) were frequent findings. Moreover, silent neurodegenerative pathologies in elderly persons were common (AD neuropathologic changes 32%, age-related neuronal and glial tau pathologies 22%, Lewy bodies 9%, argyrophilic grain disease 12.5%, TDP43 pathology 6%). Conclusions: Our results support some previous neuropathological findings of apparently multifactorial and most likely indirect brain damage in the context of SARS-CoV-2 infection rather than virus-specific damage, and they are in line with the recent experimental data on SARS-CoV-2-related diffuse white matter damage, microglial activation, and cytokine release.
Funding Information
  • Austrian Fonds of the Major of Vienna (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • Austrian Science Fund FWF, SYNABS (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • the German Academic Exchange Service (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • German Academic Scholarship Foundation (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • the Goldschmidt-Jacobson Foundation (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • National Multiple Sclerosis Society (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • the University of Basel (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • the Medical Faculty Mannheim of Heidelberg University (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • Hertie Foundation (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • European Research Council (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)
  • Deutsche Forschungsgemeinschaft (COVID038, I4685-B, FG-1708-28871, PCEPF3_194609, P1180016, DecOmPress” ERC StG, SCHI 1330/2-1/4-1)

This publication has 54 references indexed in Scilit: